Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of Liposomal Irinotecan by UGT1A1 Genotype in Pancreatic Cancer
jRCT1041200085Recruiting
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of irinotecan in pancreatic cancer (PC). Primary endpoint: Comparison of irinotecan and metabolite concentrations by UGT1A1 genotype. Started Dec 2020; status: recruiting.
02
Drugs
irinotecan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT1041200085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041200085.